Drug interactions for the following drug(s)
Applies to: Ativan 1 MG Oral Tablet <> Depakote 500 MG Delayed Release Oral Tablet
The serum concentration of Lorazepam can be increased when it is combined with Valproic Acid.
Applies to: Ativan 1 MG Oral Tablet <> chlorproMAZINE HCl 25 MG in 1 ML Injection
The risk or severity of adverse effects can be increased when Lorazepam is combined with Chlorpromazine.
Applies to: Perphenazine 8 MG Oral Tablet <> Perphenazine 8 MG Oral Tablet
The risk or severity of adverse effects can be increased when Perphenazine is combined with Perphenazine enanthate.
Applies to: Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe <> chlorproMAZINE HCl 25 MG in 1 ML Injection
Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.
Applies to: Perphenazine 8 MG Oral Tablet <> chlorproMAZINE HCl 25 MG in 1 ML Injection
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Perphenazine.
Applies to: Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe <> Depakote 500 MG Delayed Release Oral Tablet
The serum concentration of Paliperidone can be increased when it is combined with Valproic Acid.
Applies to: Ativan 1 MG Oral Tablet <> Perphenazine 8 MG Oral Tablet
The risk or severity of adverse effects can be increased when Lorazepam is combined with Perphenazine enanthate.
Applies to: Ativan 1 MG Oral Tablet <> Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe
The risk or severity of adverse effects can be increased when Lorazepam is combined with Paliperidone.
Applies to: Depakote 500 MG Delayed Release Oral Tablet <> chlorproMAZINE HCl 25 MG in 1 ML Injection
The serum concentration of Valproic Acid can be increased when it is combined with Chlorpromazine.
Applies to: Perphenazine 8 MG Oral Tablet <> Depakote 500 MG Delayed Release Oral Tablet
The metabolism of Valproic Acid can be decreased when combined with Perphenazine.
Applies to: Perphenazine 8 MG Oral Tablet <> Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe
The risk or severity of adverse effects can be increased when Perphenazine is combined with Paliperidone.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Ativan 1 MG Oral Tablet <> Depakote 500 MG Delayed Release Oral Tablet
Drug1 (rxcui = 104719, name = Lorazepam 1 MG Oral Tablet [Ativan], tty = SBD). Drug2 (rxcui = 1099871, name = Divalproex Sodium 500 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug1 is resolved to Lorazepam, Drug2 is resolved to Valproic Acid and interaction asserted in DrugBank between Lorazepam and Valproic Acid. Drug1 is resolved to Lorazepam, Drug2 is resolved to Valproate and interaction asserted in DrugBank between Lorazepam and Valproic Acid.
Applies to: Ativan 1 MG Oral Tablet <> chlorproMAZINE HCl 25 MG in 1 ML Injection
Drug1 (rxcui = 104719, name = Lorazepam 1 MG Oral Tablet [Ativan], tty = SBD). Drug2 (rxcui = 1730076, name = 1 ML Chlorpromazine hydrochloride 25 MG/ML Injection, tty = SCD). Drug1 is resolved to Chlorpromazine, Drug2 is resolved to Lorazepam and interaction asserted in DrugBank between Chlorpromazine and Lorazepam.
Applies to: Perphenazine 8 MG Oral Tablet <> Perphenazine 8 MG Oral Tablet
Drug1 (rxcui = 198078, name = Perphenazine 8 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 198078, name = Perphenazine 8 MG Oral Tablet, tty = SCD). Drug1 is resolved to Perphenazine, Drug2 is resolved to perphenazine enanthate and interaction asserted in DrugBank between Perphenazine and Perphenazine enanthate. Drug1 is resolved to perphenazine enanthate, Drug2 is resolved to Perphenazine and interaction asserted in DrugBank between Perphenazine enanthate and Perphenazine.
Applies to: Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe <> chlorproMAZINE HCl 25 MG in 1 ML Injection
Drug1 (rxcui = 858051, name = 0.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega], tty = SBD). Drug2 (rxcui = 1730076, name = 1 ML Chlorpromazine hydrochloride 25 MG/ML Injection, tty = SCD). Drug1 is resolved to Chlorpromazine, Drug2 is resolved to paliperidone and interaction asserted in DrugBank between Chlorpromazine and Paliperidone.
Applies to: Perphenazine 8 MG Oral Tablet <> chlorproMAZINE HCl 25 MG in 1 ML Injection
Drug1 (rxcui = 198078, name = Perphenazine 8 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1730076, name = 1 ML Chlorpromazine hydrochloride 25 MG/ML Injection, tty = SCD). Drug1 is resolved to Chlorpromazine, Drug2 is resolved to Perphenazine and interaction asserted in DrugBank between Chlorpromazine and Perphenazine. Drug1 is resolved to Chlorpromazine, Drug2 is resolved to perphenazine enanthate and interaction asserted in DrugBank between Chlorpromazine and Perphenazine enanthate.
Applies to: Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe <> Depakote 500 MG Delayed Release Oral Tablet
Drug1 (rxcui = 858051, name = 0.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega], tty = SBD). Drug2 (rxcui = 1099871, name = Divalproex Sodium 500 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug1 is resolved to Valproic Acid, Drug2 is resolved to paliperidone and interaction asserted in DrugBank between Valproic Acid and Paliperidone. Drug1 is resolved to Valproate, Drug2 is resolved to paliperidone and interaction asserted in DrugBank between Valproic Acid and Paliperidone.
Applies to: Ativan 1 MG Oral Tablet <> Perphenazine 8 MG Oral Tablet
Drug1 (rxcui = 104719, name = Lorazepam 1 MG Oral Tablet [Ativan], tty = SBD). Drug2 (rxcui = 198078, name = Perphenazine 8 MG Oral Tablet, tty = SCD). Drug1 is resolved to Lorazepam, Drug2 is resolved to perphenazine enanthate and interaction asserted in DrugBank between Lorazepam and Perphenazine enanthate. Drug1 is resolved to Lorazepam, Drug2 is resolved to Perphenazine and interaction asserted in DrugBank between Lorazepam and Perphenazine.
Applies to: Ativan 1 MG Oral Tablet <> Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe
Drug1 (rxcui = 104719, name = Lorazepam 1 MG Oral Tablet [Ativan], tty = SBD). Drug2 (rxcui = 858051, name = 0.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega], tty = SBD). Drug1 is resolved to Lorazepam, Drug2 is resolved to paliperidone and interaction asserted in DrugBank between Lorazepam and Paliperidone.
Applies to: Depakote 500 MG Delayed Release Oral Tablet <> chlorproMAZINE HCl 25 MG in 1 ML Injection
Drug1 (rxcui = 1099871, name = Divalproex Sodium 500 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug2 (rxcui = 1730076, name = 1 ML Chlorpromazine hydrochloride 25 MG/ML Injection, tty = SCD). Drug1 is resolved to Chlorpromazine, Drug2 is resolved to Valproate and interaction asserted in DrugBank between Chlorpromazine and Valproic Acid. Drug1 is resolved to Chlorpromazine, Drug2 is resolved to Valproic Acid and interaction asserted in DrugBank between Chlorpromazine and Valproic Acid.
Applies to: Perphenazine 8 MG Oral Tablet <> Depakote 500 MG Delayed Release Oral Tablet
Drug1 (rxcui = 198078, name = Perphenazine 8 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099871, name = Divalproex Sodium 500 MG Delayed Release Oral Tablet [Depakote], tty = SBD). Drug1 is resolved to Perphenazine, Drug2 is resolved to Valproate and interaction asserted in DrugBank between Perphenazine and Valproic Acid. Drug1 is resolved to Valproic Acid, Drug2 is resolved to perphenazine enanthate and interaction asserted in DrugBank between Valproic Acid and Perphenazine enanthate. Drug1 is resolved to Perphenazine, Drug2 is resolved to Valproic Acid and interaction asserted in DrugBank between Perphenazine and Valproic Acid. Drug1 is resolved to perphenazine enanthate, Drug2 is resolved to Valproate and interaction asserted in DrugBank between Perphenazine enanthate and Valproic Acid.
Applies to: Perphenazine 8 MG Oral Tablet <> Invega Sustenna 78 MG per 0.5 ML Extended Release Injectable Suspension in a Prefilled Syringe
Drug1 (rxcui = 198078, name = Perphenazine 8 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 858051, name = 0.5 ML paliperidone palmitate 156 MG/ML Prefilled Syringe [Invega], tty = SBD). Drug1 is resolved to Perphenazine, Drug2 is resolved to paliperidone and interaction asserted in DrugBank between Perphenazine and Paliperidone. Drug1 is resolved to perphenazine enanthate, Drug2 is resolved to paliperidone and interaction asserted in DrugBank between Perphenazine enanthate and Paliperidone.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.